Guest Editorial As cancer research is threatened, we must engage in political advocacy February 21, 2025Vol.51 No.07By George J. Weiner
Black History MonthConversation with The Cancer LetterFree Brian Rivers: Celebrating Black history reinforces the dynamic culture of America“It gives America, in part, its identity.” February 21, 2025Vol.51 No.07By Jacquelyn Cobb
FreeObituary John Zaia, virologist and gene therapy pioneer, dies at 82 February 21, 2025Vol.51 No.07By Samantha Bonar and Abe Rosenberg
Black History MonthFreePodcastThe Directors On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centersThe Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty February 14, 2025Vol.51 No.06By Paul Goldberg
FreeGuest Editorial Preparing to take care of each other in ways we never imagined February 14, 2025Vol.51 No.06By W. Kimryn Rathmell
Guest Editorial From the chairs of ECOG-ACRIN: A perspective on indirect costs February 14, 2025Vol.51 No.06By Peter J. O'Dwyer and Mitchell D. Schnall
White House RFK Jr. is confirmed, NCORP stops collecting data on sexual orientation, genderOne month in: Trump’s impact on oncology February 14, 2025Vol.51 No.06By Claire Marie Porter and Jacquelyn Cobb
Cancer History ProjectFreePodcast 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect February 14, 2025Vol.51 No.06By Yiqing Wang
Sponsored The War on Cancer: After half a century of progress, a promising prognosis may be Richard Nixon’s greatest legacy February 14, 2025Vol.51 No.06By Jim Byron
White House Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutionsThe move could gut academic cancer research February 10, 2025Vol.51 No.06By Paul Goldberg
